Literature DB >> 17277912

Tau missing from CSF: a case report.

Antonella Alberici, Mario Armani, Anna Paterlini, Luisa Benussi, Francesca Nicosia, Roberta Ghidoni, Simona Signorini, Maria Cotelli, Giovanni B Frisoni, Cristina Geroldi, Carlo P Trevisan, John H Growdon, Barbara Borroni, Alessandro Padovani, Paolo M Rossini, Giuliano Binetti.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17277912     DOI: 10.1007/s00415-006-0282-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  13 in total

1.  Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia.

Authors:  V Zhukareva; V Vogelsberg-Ragaglia; V M Van Deerlin; J Bruce; T Shuck; M Grossman; C M Clark; S E Arnold; E Masliah; D Galasko; J Q Trojanowski; V M Lee
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

2.  Frontotemporal dementia: impact of P301L tau mutation on a healthy carrier.

Authors:  A Alberici; C Gobbo; A Panzacchi; F Nicosia; R Ghidoni; L Benussi; C Hock; A Papassotiropoulos; P Liberini; J H Growdon; G B Frisoni; A Villa; O Zanetti; S Cappa; F Fazio; G Binetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

3.  Cerebrospinal fluid tau levels in frontotemporal dementia.

Authors:  Marcel M Verbeek; Yolande A Pijnenburg; Niki S Schoonenboom; Berry P H Kremer; Philip Scheltens
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

4.  Neuropsychological and behavioural correlates of CSF biomarkers in dementia.

Authors:  Sebastiaan Engelborghs; Karen Maertens; Ellen Vloeberghs; Tony Aerts; Nore Somers; Peter Mariën; Peter P De Deyn
Journal:  Neurochem Int       Date:  2006-01-24       Impact factor: 3.921

5.  Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study.

Authors:  Victoria Zhukareva; Sonali Sundarraj; David Mann; Magnus Sjogren; Kaj Blenow; Christopher M Clark; Daniel W McKeel; Alison Goate; Carol F Lippa; Jean-Paul Vonsattel; John H Growdon; John Q Trojanowski; Virginia M-Y Lee
Journal:  Acta Neuropathol       Date:  2003-01-25       Impact factor: 17.088

6.  CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimaging.

Authors:  Y A L Pijnenburg; S N M Schoonenboom; F Barkhof; D L Knol; C Mulder; G J Van Kamp; J C Van Swieten; P Scheltens
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

7.  Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology.

Authors:  H Arai; Y Morikawa; M Higuchi; T Matsui; C M Clark; M Miura; N Machida; V M Lee; J Q Trojanowski; H Sasaki
Journal:  Biochem Biophys Res Commun       Date:  1997-07-18       Impact factor: 3.575

8.  Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias.

Authors:  Ryan T Mott; Dennis W Dickson; John Q Trojanowski; Vicki Zhukareva; Virginia M Lee; Mark Forman; Vivianna Van Deerlin; John F Ervin; Deng-Shun Wang; Donald E Schmechel; Christine M Hulette
Journal:  J Neuropathol Exp Neurol       Date:  2005-05       Impact factor: 3.685

9.  Atypical dementia associated with a novel presenilin-2 mutation.

Authors:  Giuliano Binetti; Simona Signorini; Rosanna Squitti; Antonella Alberici; Luisa Benussi; Emanuele Cassetta; Giovanni Battista Frisoni; Laura Barbiero; Enrica Feudatari; Francesca Nicosia; Cristina Testa; Orazio Zanetti; Massimo Gennarelli; Daniela Perani; Davide Anchisi; Roberta Ghidoni; Paolo Maria Rossini
Journal:  Ann Neurol       Date:  2003-12       Impact factor: 10.422

10.  Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

Authors:  M Riemenschneider; S Wagenpfeil; J Diehl; N Lautenschlager; T Theml; B Heldmann; A Drzezga; T Jahn; H Förstl; A Kurz
Journal:  Neurology       Date:  2002-06-11       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.